franklin fin svc - FRAF
FRAF
Close Chg Chg %
63.12 -0.32 -0.51%
Open Market
62.80
-0.32 (0.51%)
Volume: 19.84K
Last Updated:
Sep 9, 2026, 12:00 PM EDT
Company Overview: franklin fin svc - FRAF
FRAF Key Data
| Open $62.42 | Day Range 61.68 - 62.97 |
| 52 Week Range 43.47 - 65.41 | Market Cap $289.14M |
| Shares Outstanding 4.50M | Public Float 4.17M |
| Beta -0.02 | Rev. Per Employee N/A |
| P/E Ratio 11.71 | EPS $5.50 |
| Yield 212.29% | Dividend $0.34 |
| EX-DIVIDEND DATE Aug 7, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 33.44K |
FRAF Performance
| 1 Week | -1.77% | ||
| 1 Month | 1.28% | ||
| 3 Months | 3.78% | ||
| 1 Year | 33.22% | ||
| 5 Years | 102.63% |
FRAF Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
1
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 64.00 | |
| Number of Ratings | 1 | Current Quarters Estimate | 1.447 | |
| FY Report Date | 09 / 2026 | Current Year's Estimate | 5.792 | |
| Last Quarter’s Earnings | 1.47 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 4.74 | Next Fiscal Year Estimate | 6.588 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 1 | 1 | 1 | 1 |
| Mean Estimate | 1.45 | 1.46 | 5.79 | 6.59 |
| High Estimates | 1.45 | 1.46 | 5.79 | 6.59 |
| Low Estimate | 1.45 | 1.46 | 5.79 | 6.59 |
| Coefficient of Variance | N/A | N/A | N/A | N/A |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 0 | 0 | 0 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Franklin Fin Svc - FRAF
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Franklin Fin Svc - FRAF
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Gregory A. Duffey Director | 24,028 | Open market or private purchase of non-derivative security Non-derivative transaction at $62.08 per share | 1,491,658.24 |
| Jun 3, 2026 | Mark R. Hollar SEVP/CFO | 17,296 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $47.51 per share | 821,732.96 |
| Jun 3, 2026 | Karen K. Carmack SVP, Chief HR Officer | 5,482 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $47.51 per share | 260,449.82 |
| Jun 3, 2026 | David M. Long SVP, Chief Technology Officer | 1,601 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $47.51 per share | 76,063.51 |
| Jun 3, 2026 | Louis J Giustini SVP, CRSO | 1,933 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $47.51 per share | 91,836.83 |
| Jun 3, 2026 | Charles B. Carroll President & COO | 6,035 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $47.51 per share | 286,722.85 |
| Jun 3, 2026 | Craig W. Best CEO | 17,559 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $47.51 per share | 834,228.09 |
| Jun 2, 2026 | Steven D. Butz EVP, CCSO | 5,610 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $57.73 per share | 323,865.30 |
| Mar 31, 2026 | Gregory I. Snook Director | 9,416 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $50.56 per share | 476,072.96 |
| Mar 31, 2026 | Kevin W. Craig Director | 27,594 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $50.56 per share | 1,395,152.64 |
| Mar 31, 2026 | Daniel J. Fisher Director | 30,240 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $50.56 per share | 1,528,934.40 |
| Mar 31, 2026 | Stanley J. Kerlin Director | 27,070 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $50.56 per share | 1,368,659.20 |
| Mar 31, 2026 | G. Warren Elliott Director | 18,013 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $50.56 per share | 910,737.28 |
| Mar 25, 2026 | Lorie M. Heckman EVP, Chief Risk Officer | 7,150 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $34.1 per share | 243,815.00 |
| Mar 25, 2026 | Lorie M. Heckman EVP, Chief Risk Officer | 2,500 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 4, 2026 | Kimberly M. Rzomp Director | 6,185 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Dec 19, 2025 | Martin R. Brown Director | 9,301 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $55.32 per share | 514,531.32 |
| Dec 19, 2025 | Steven D. Butz EVP, CCSO | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Dec 19, 2025 | Steven D. Butz EVP, CCSO | 6,602 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $56.12 per share | 370,504.24 |
| Dec 16, 2025 | Donald H. Mowery Director | 44,685 | Bona fide gift | 0.00 |